Follow
Caroline Heckman
Caroline Heckman
University of Helsinki, Institute for Molecular Medicine Finland FIMM-HiLIFE
Verified email at helsinki.fi - Homepage
Title
Cited by
Cited by
Year
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
HLM Koskela, S Eldfors, P Ellonen, AJ van Adrichem, H Kuusanmäki, ...
New England Journal of Medicine 366 (20), 1905-1913, 2012
7312012
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid LeukemiaISM Approach to Therapy Selection
T Pemovska, M Kontro, B Yadav, H Edgren, S Eldfors, A Szwajda, ...
Cancer discovery 3 (12), 1416-1429, 2013
372*2013
Functional interaction of VEGF‐C and VEGF‐D with neuropilin receptors
T Karpanen, CA Heckman, S Keskitalo, M Jeltsch, H Ollila, G Neufeld, ...
The FASEB Journal 20 (9), 1462-1472, 2006
3632006
Comparison of solution-based exome capture methods for next generation sequencing
AM Sulonen, P Ellonen, H Almusa, M Lepistö, S Eldfors, S Hannula, ...
Genome biology 12 (9), 1-18, 2011
3112011
Histone Deacetylase Inhibitors Down-Regulate bcl-2 Expression and Induce Apoptosis in t(14;18) Lymphomas
H Duan, CA Heckman, LM Boxer
Molecular and cellular biology 25 (5), 1608-1619, 2005
3012005
Negative regulation of bcl-2 expression by p53 in hematopoietic cells
Y Wu, JW Mehew, CA Heckman, M Arcinas, LM Boxer
Oncogene 20 (2), 240-251, 2001
2842001
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
HLM Rajala, S Eldfors, H Kuusanmäki, AJ Van Adrichem, T Olson, ...
Blood, The Journal of the American Society of Hematology 121 (22), 4541-4550, 2013
2742013
Use of cancer‐specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors
DJ McBride, AK Orpana, C Sotiriou, H Joensuu, PJ Stephens, LJ Mudie, ...
Genes, Chromosomes and Cancer 49 (11), 1062-1069, 2010
2742010
NF-κB activates Bcl-2 expression in t (14; 18) lymphoma cells
CA Heckman, JW Mehew, LM Boxer
Oncogene 21 (24), 3898-3908, 2002
2472002
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies
B Yadav, T Pemovska, A Szwajda, E Kulesskiy, M Kontro, R Karjalainen, ...
Scientific reports 4 (1), 1-10, 2014
2432014
The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis
CA Heckman, T Holopainen, M Wirzenius, S Keskitalo, M Jeltsch, ...
Cancer Research 68 (12), 4754-4762, 2008
1142008
The WT1 Protein Is a Negative Regulator of the Normalbcl-2 Allele in t (14; 18) Lymphomas
C Heckman, E Mochon, M Arcinas, LM Boxer
Journal of Biological Chemistry 272 (31), 19609-19614, 1997
1091997
Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
M Kontro, H Kuusanmäki, S Eldfors, T Burmeister, EI Andersson, ...
Leukemia 28 (8), 1738-1742, 2014
1042014
JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell–induced protection of AML
R Karjalainen, T Pemovska, M Popa, M Liu, KK Javarappa, MM Majumder, ...
Blood, The Journal of the American Society of Hematology 130 (6), 789-802, 2017
942017
A-Myb up-regulates Bcl-2 through a Cdx binding site in t (14; 18) lymphoma cells
CA Heckman, JW Mehew, GG Ying, M Introna, J Golay, LM Boxer
Journal of Biological Chemistry 275 (9), 6499-6508, 2000
812000
Comprehensive drug testing of patient-derived conditionally reprogrammed cells from castration-resistant prostate cancer
K Saeed, V Rahkama, S Eldfors, D Bychkov, JP Mpindi, B Yadav, ...
European urology 71 (3), 319-327, 2017
742017
Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer
A Malyutina, MM Majumder, W Wang, A Pessia, CA Heckman, J Tang
PLoS computational biology 15 (5), e1006752, 2019
712019
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
M Kontro, A Kumar, MM Majumder, S Eldfors, A Parsons, T Pemovska, ...
Leukemia 31 (2), 301-309, 2017
702017
Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation
EI Andersson, HLM Rajala, S Eldfors, P Ellonen, T Olson, A Jerez, ...
Blood cancer journal 3 (12), e168-e168, 2013
692013
Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma
M Arcinas, CA Heckman, JW Mehew, LM Boxer
Cancer research 61 (13), 5202-5206, 2001
692001
The system can't perform the operation now. Try again later.
Articles 1–20